Trupanion (NASDAQ:TRUP) Price Target Raised to $44.00

Trupanion (NASDAQ:TRUPFree Report) had its price objective boosted by Stifel Nicolaus from $42.00 to $44.00 in a research note issued to investors on Monday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the financial services provider’s stock.

Several other analysts also recently weighed in on the company. Bank of America boosted their price objective on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Piper Sandler lifted their target price on shares of Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, October 31st. Finally, Northland Securities increased their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Trupanion currently has a consensus rating of “Moderate Buy” and an average price target of $45.33.

Read Our Latest Research Report on Trupanion

Trupanion Trading Down 1.9 %

Shares of TRUP stock opened at $46.58 on Monday. Trupanion has a 1 year low of $19.69 and a 1 year high of $57.90. The company’s fifty day simple moving average is $51.80 and its two-hundred day simple moving average is $44.72. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. The stock has a market capitalization of $1.97 billion, a price-to-earnings ratio of -145.56 and a beta of 1.61.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The business had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same period in the previous year, the business posted ($0.10) earnings per share. Trupanion’s revenue for the quarter was up 14.6% on a year-over-year basis. As a group, analysts anticipate that Trupanion will post -0.23 earnings per share for the current year.

Insider Transactions at Trupanion

In other Trupanion news, SVP Emily Dreyer sold 3,100 shares of the stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $54.85, for a total transaction of $170,035.00. Following the completion of the transaction, the senior vice president now owns 24,708 shares of the company’s stock, valued at $1,355,233.80. This represents a 11.15 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Murray B. Low sold 2,000 shares of the firm’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total transaction of $105,340.00. Following the completion of the transaction, the director now directly owns 131,513 shares of the company’s stock, valued at approximately $6,926,789.71. This trade represents a 1.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 28,597 shares of company stock valued at $1,522,082 over the last quarter. 5.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Trupanion

A number of large investors have recently bought and sold shares of the business. FMR LLC increased its holdings in shares of Trupanion by 55,963.7% during the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after acquiring an additional 1,170,202 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in Trupanion in the 2nd quarter valued at $4,739,000. Marshall Wace LLP increased its stake in Trupanion by 11.9% during the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after acquiring an additional 116,496 shares during the last quarter. Connors Investor Services Inc. increased its position in shares of Trupanion by 31.3% during the 2nd quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock worth $3,339,000 after purchasing an additional 27,042 shares during the last quarter. Finally, Dalton Investments Inc. purchased a new stake in shares of Trupanion in the 2nd quarter valued at approximately $1,029,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Recommended Stories

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.